TecDAX

At CES 2026, Intel delivered a pivotal message to the market. The semiconductor giant announced the on-schedule—and according to management,...

Investors in Mainz-based biotechnology firm BioNTech are navigating a complex landscape of strategic progress and fresh legal uncertainty. The company...

A definitive chapter has closed for investors in CureVac. The German biotech firm's standalone history as a publicly traded company...

The financial world’s attention is fixed on Las Vegas as the technology sector converges for CES 2026. In the hours...

The new trading year has begun on a positive note for CureVac, with its shares posting significant gains. This upward...

Despite a challenging year for its share price, BioNTech concludes 2025 in a stronger strategic and financial position than market...

As the year draws to a close, Fortinet finds its stock under pressure. This comes despite the cybersecurity firm posting...

The German biotech firm BioNTech is decisively pivoting beyond its pandemic-era identity, placing a substantial strategic bet on mRNA oncology....

A significant realignment is underway among the major shareholders of Teradyne. Recent regulatory filings reveal that institutional investors now control...

Following a period of significant volatility, shares of semiconductor specialist Wolfspeed have shown initial signs of stabilization this December. A...